Similarly, in a previous study fractalkine and its receptor (CX3CR1) were increased in circulation as well as in atherosclerotic plaque in coronary artery disease [27], providing a potential link between uremic toxicity and accelerated atherogenesis. The gene discussed is CX3CR1; the disease is coronary artery disorder.